Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedApr 20, 2026
DataAggregated Company Financials
Companies204
  • 7D-1.2%
  • 3M3.9%
  • 1Y19.5%
  • YTD3.9%

Over the last 7 days, the Healthcare industry has dropped 1.2%, driven by declines in Shionogi and Takeda Pharmaceutical of 5.1% and 1.4%, respectively. Meanwhile, Daiichi Sankyo Company actually outperformed within the industry, gaining 9.5% in the last week. Over the past 12 months, the industry was up 19%. Looking forward, earnings are forecast to grow by 9.4% annually.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 20 Apr 2026JP¥74.0tJP¥38.8tJP¥3.1t15.5x24.1x1.9x
Wed, 18 Mar 2026JP¥74.9tJP¥38.9tJP¥3.1t15.8x24.4x1.9x
Fri, 13 Feb 2026JP¥75.7tJP¥38.7tJP¥3.2t16.4x23.9x2x
Sun, 11 Jan 2026JP¥73.1tJP¥38.4tJP¥2.7t16.7x26.6x1.9x
Tue, 09 Dec 2025JP¥69.9tJP¥38.5tJP¥2.8t16.1x25.4x1.8x
Thu, 06 Nov 2025JP¥65.8tJP¥38.3tJP¥2.8t15.3x23.7x1.7x
Sat, 04 Oct 2025JP¥65.1tJP¥38.2tJP¥2.7t15.6x24.3x1.7x
Mon, 01 Sep 2025JP¥63.7tJP¥38.2tJP¥2.7t16.1x23.8x1.7x
Wed, 30 Jul 2025JP¥64.3tJP¥38.1tJP¥2.6t15.1x24.5x1.7x
Fri, 27 Jun 2025JP¥62.5tJP¥38.1tJP¥2.6t14.5x23.7x1.6x
Sun, 25 May 2025JP¥62.6tJP¥38.0tJP¥2.6t14x23.7x1.6x
Tue, 22 Apr 2025JP¥62.0tJP¥37.5tJP¥2.4t14.3x25.9x1.7x
Thu, 20 Mar 2025JP¥63.5tJP¥37.5tJP¥2.4t15x26.6x1.7x
Sat, 15 Feb 2025JP¥64.4tJP¥37.4tJP¥2.2t15.6x29.2x1.7x
Mon, 13 Jan 2025JP¥65.6tJP¥36.5tJP¥2.2t16.7x29.5x1.8x
Wed, 11 Dec 2024JP¥67.6tJP¥36.7tJP¥2.2t16.2x30.1x1.8x
Fri, 08 Nov 2024JP¥70.7tJP¥36.5tJP¥2.2t17.3x32.4x1.9x
Sun, 06 Oct 2024JP¥70.1tJP¥36.0tJP¥2.0t17.5x35.3x1.9x
Tue, 03 Sep 2024JP¥72.8tJP¥36.0tJP¥2.0t17.9x36.6x2x
Thu, 01 Aug 2024JP¥71.3tJP¥35.2tJP¥1.9t18.2x38.3x2x
Sat, 29 Jun 2024JP¥67.3tJP¥35.3tJP¥1.9t17.7x36x1.9x
Mon, 27 May 2024JP¥64.3tJP¥35.3tJP¥1.9t17.2x34.4x1.8x
Wed, 24 Apr 2024JP¥63.1tJP¥34.7tJP¥1.9t17.3x32.4x1.8x
Fri, 22 Mar 2024JP¥69.2tJP¥35.1tJP¥2.0t18.8x35.2x2x
Sun, 18 Feb 2024JP¥67.4tJP¥35.1tJP¥2.0t18.7x34.4x1.9x
Tue, 16 Jan 2024JP¥67.8tJP¥35.0tJP¥2.2t18.3x31.4x1.9x
Thu, 14 Dec 2023JP¥63.2tJP¥35.0tJP¥2.2t17.8x29.4x1.8x
Sat, 11 Nov 2023JP¥61.5tJP¥34.9tJP¥2.1t17.6x28.8x1.8x
Mon, 09 Oct 2023JP¥61.5tJP¥34.5tJP¥2.3t17.5x27.1x1.8x
Wed, 06 Sep 2023JP¥65.1tJP¥34.5tJP¥2.3t18.2x28.7x1.9x
Fri, 04 Aug 2023JP¥63.4tJP¥34.2tJP¥2.3t18.6x27.8x1.9x
Sun, 02 Jul 2023JP¥65.4tJP¥33.9tJP¥2.3t18.5x28.2x1.9x
Tue, 30 May 2023JP¥64.2tJP¥33.9tJP¥2.3t18.5x27.8x1.9x
Thu, 27 Apr 2023JP¥61.5tJP¥33.5tJP¥2.3t16.9x26.7x1.8x
Price to Earnings Ratio

26.7x


Total Market Cap: JP¥61.5tTotal Earnings: JP¥2.3tTotal Revenue: JP¥33.5tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 28.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Japanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.1x which is lower than its 3-year average PE of 28.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 10% per year over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market0.68%
Healthcare-1.21%
Biotech3.39%
Life Sciences1.48%
Healthtech0.24%
Medical Equipment-0.39%
Healthcare Services-1.54%
Pharma-1.67%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 31.1x.
    • Analysts are expecting annual earnings growth of 10.3%, which is higher than its past year's earnings decline of 3.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 41% over the next 5 years.
  • This is better than its past earnings decline of 20% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 3.1% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4568 Daiichi Sankyo CompanyJP¥3.00k9.8%
+JP¥492.4b		-5.8%PE18.1x
4519 Chugai PharmaceuticalJP¥8.84k3.0%
+JP¥426.3b		5.0%PE33.5x
7741 HOYAJP¥29.65k1.6%
+JP¥159.4b		90.0%PE39.7x
4543 TerumoJP¥2.21k3.4%
+JP¥105.5b		-18.4%PE25.4x
4578 Otsuka HoldingsJP¥10.69k1.9%
+JP¥105.5b		61.6%PE15.5x

Latest News

4151
JP¥2,469.00
Kyowa Kirin
7D
-1.2%
1Y
12.4%
4568
JP¥3,000.00
Daiichi Sankyo Company
7D
9.8%
1Y
-5.8%
4543
JP¥2,205.50
Terumo
7D
3.4%
1Y
-18.4%

4543: AI Partnerships Will Support Future Earnings And Dividend Expansion

Analysts have nudged their Terumo price target slightly lower to ¥2,872 from ¥2,918, reflecting updated views on discount rates, revenue growth assumptions, profit margins, and future P/E levels. What's in the News Terumo is holding an Analyst and Investor Day to share more detail on its mid to long term growth drivers, giving you more visibility into how management frames the business over time.
7459
JP¥2,778.00
MediPal Holdings
7D
-2.9%
1Y
17.4%
4578
JP¥10,685.00
Otsuka Holdings
7D
1.9%
1Y
61.6%

4578: Morgan Stanley Upgrade And Buybacks Will Shape Balanced Forward Expectations

Analysts have raised their price target for Otsuka Holdings from ¥10,850 to ¥11,650, citing updated expectations for revenue growth, profit margins, and future P/E that align with recent Street research, including the upgrade highlighted by Morgan Stanley. Analyst Commentary Bullish Takeaways Bullish analysts view the higher price target of ¥11,650 as more in line with updated expectations for revenue growth and profit margins that are reflected in recent Street work.
4507
JP¥3,213.00
Shionogi
7D
-4.8%
1Y
33.5%
7733
JP¥1,578.50
Olympus
7D
2.8%
1Y
-12.0%

7733: Medtech M&A And Imaging Platform Expansion Will Support Future Upside Potential

Analysts have trimmed the Olympus price target from ¥2,400 to ¥2,300, reflecting updated assumptions around slightly softer revenue growth, lower profit margins, and a higher discount rate, partly offset by a higher future P/E multiple. What's in the News Launched the VISERA ELITE III surgical imaging platform in the U.S., a software driven system that combines True 4K and 3D imaging, Narrow Band Imaging technology, Yellow Enhancement, fluorescence guided surgery, and ENDOEYE scopes in a single platform designed to support multiple surgical specialties and existing Olympus equipment (Product related announcement).
4502
JP¥5,575.00
Takeda Pharmaceutical
7D
-1.1%
1Y
32.4%

4502: Fair Outlook Will Depend On Late Stage Pipeline And Legal Outcomes

Analysts have adjusted their price target on Takeda Pharmaceutical from about ¥5,697 to roughly ¥6,004, reflecting updated assumptions around revenue growth, profit margins, and future P/E expectations. What's in the News Takeda plans a leadership transition, with current CEO Christophe Weber set to retire at the 150th Ordinary General Meeting of Shareholders on June 24, 2026.
4519
JP¥8,844.00
Chugai Pharmaceutical
7D
3.0%
1Y
5.0%
6960
JP¥9,950.00
Fukuda Denshi
7D
-6.9%
1Y
66.1%
4528
JP¥2,429.50
Ono Pharmaceutical
7D
-2.5%
1Y
39.9%
7741
JP¥29,645.00
HOYA
7D
1.6%
1Y
90.0%
6869
JP¥1,437.50
Sysmex
7D
3.8%
1Y
-46.5%
7747
JP¥3,465.00
Asahi Intecc
7D
-1.6%
1Y
62.9%
4506
JP¥2,073.00
Sumitomo Pharma
7D
5.2%
1Y
230.6%
4536
JP¥1,752.00
Santen Pharmaceutical
7D
-3.0%
1Y
24.7%